Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Day

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 13, 2014
A comparative study of ERG status assessment on DNA, mRNA, and protein levels using unique samples from a Swedish biopsy cohortMaria A Svensson, Sven Perner, Anna-Lena Ohlson, et al.
The Journal of Urology|February 26, 2008
PCA3: a molecular urine assay for predicting prostate biopsy outcomeIna L Deras, Sheila M J Aubin, Amy Blase, et al.
European Urology|May 20, 2015
Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk AssessmentScott A Tomlins, John R Day, Robert J Lonigro, et al.
Urology|December 19, 2009
ERG rearrangement metastasis patterns in locally advanced prostate cancerSven Perner, Maria A Svensson, Ruhella R Hossain, et al.
Science Translational Medicine|August 5, 2011
Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSAScott A Tomlins, Sheila M J Aubin, Javed Siddiqui, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 13, 2014
A comparative study of ERG status assessment on DNA, mRNA, and protein levels using unique samples from a Swedish biopsy cohortMaria A Svensson, Sven Perner, Anna-Lena Ohlson, et al.
The Journal of Urology|February 26, 2008
PCA3: a molecular urine assay for predicting prostate biopsy outcomeIna L Deras, Sheila M J Aubin, Amy Blase, et al.
European Urology|May 20, 2015
Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk AssessmentScott A Tomlins, John R Day, Robert J Lonigro, et al.
Urology|December 19, 2009
ERG rearrangement metastasis patterns in locally advanced prostate cancerSven Perner, Maria A Svensson, Ruhella R Hossain, et al.
Science Translational Medicine|August 5, 2011
Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSAScott A Tomlins, Sheila M J Aubin, Javed Siddiqui, et al.
Pageof 2